Related references
Note: Only part of the references are listed.Modulatory Effects of Fingolimod (FTY720) on the Expression of Sphingolipid Metabolism-Related Genes in an Animal Model of Alzheimer's Disease
Henryk Jesko et al.
MOLECULAR NEUROBIOLOGY (2019)
Sphingolipid metabolism in non-alcoholic fatty liver diseases
Marion Regnier et al.
BIOCHIMIE (2019)
Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells
Cecile L. Bandet et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders
Kinga Czubowicz et al.
MOLECULAR NEUROBIOLOGY (2019)
Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model
Antoine Leboucher et al.
NEUROBIOLOGY OF DISEASE (2019)
Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease
Burkhard Kleuser
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Comparative Analysis of EPA/DHA-PL Forage and Liposomes in Orotic Acid-Induced Nonalcoholic Fatty Liver Rats and Their Related Mechanisms
Mengru Chang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)
Homocysteine and Dementia: An International Consensus Statement
A. David Smith et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances beta-cell function of obese Zucker rats
Melanie Campana et al.
MOLECULAR METABOLISM (2018)
Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer's disease brain
Gaelle Dominguez et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Homocysteine-lowering gene therapy rescues signaling pathways in brain of mice with intermediate hyperhomocysteinemia
Vanessa Baloula et al.
REDOX BIOLOGY (2018)
Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma
Rosa M. Pascale et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation
Stefan Hajny et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease
Min Kim et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Tau deletion promotes brain insulin resistance
Elodie Marciniak et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans
Leonore Wigger et al.
CELL REPORTS (2017)
Sphingolipids: membrane microdomains in brain development, function and neurological diseases
Anne S. B. Olsen et al.
OPEN BIOLOGY (2017)
Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer's disease
N. Janel et al.
TRANSLATIONAL PSYCHIATRY (2017)
Molecular phenotyping of multiple mouse strains under metabolic challenge uncovers a role for Elovl2 in glucose-induced insulin secretion
Celine Cruciani-Guglielmacci et al.
MOLECULAR METABOLISM (2017)
Omega-3 PUFA ameliorates hyperhomocysteinemia-induced hepatic steatosis in mice by inhibiting hepatic ceramide synthesis
Yong-qiang Dong et al.
ACTA PHARMACOLOGICA SINICA (2017)
The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind
Roberta Ricciarelli et al.
CURRENT NEUROPHARMACOLOGY (2017)
Dyrk1 inhibition improves Alzheimer's disease-like pathology
Caterina Branca et al.
AGING CELL (2017)
Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner
Eiji Kakazu et al.
JOURNAL OF LIPID RESEARCH (2016)
Homocysteine, B Vitamins, and Cognitive Impairment
A. David Smith et al.
ANNUAL REVIEW OF NUTRITION, VOL 36 (2016)
Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ
Jinbiao Chen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
Impact of Dyrk1A level on alcohol metabolism
Marjorie Renon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model
Do-Geun Kim et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Association of Vitamin B12, Folate, and Sulfur Amino Acids With Brain Magnetic Resonance Imaging Measures in Older Adults A Longitudinal Population-Based Study
Babak Hooshmand et al.
JAMA PSYCHIATRY (2016)
Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes
Lara Bellini et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
SphK1 mediates hepatic inflammation in a mouse model of NASH induced by high saturated fat feeding and initiates proinflammatory signaling in hepatocytes
Tuoyu Geng et al.
JOURNAL OF LIPID RESEARCH (2015)
A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
Peng Wang et al.
NATURE MEDICINE (2015)
Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis
Yozo Yoshimine et al.
ONCOLOGY REPORTS (2015)
Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
Weijun Shen et al.
NATURE COMMUNICATIONS (2015)
Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment
Sasanka Chakrabarti et al.
AGING AND DISEASE (2015)
Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation
Mini P. Sajan et al.
JOURNAL OF LIPID RESEARCH (2015)
Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype
Susann Fayyaz et al.
DIABETOLOGIA (2014)
Plasma DYRK1A as a novel risk factor for Alzheimer's disease
N. Janel et al.
TRANSLATIONAL PSYCHIATRY (2014)
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis
Timothy A. Couttas et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
One-carbon cycle alterations induced by Dyrk1a dosage
Jean-Maurice Delabar et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2014)
Influence of Metabolism on Epigenetics and Disease
William G. Kaelin et al.
CELL (2013)
Ceramides Contained in LDL Are Elevated in Type 2 Diabetes and Promote Inflammation and Skeletal Muscle Insulin Resistance
James Boon et al.
DIABETES (2013)
Mice Deficient in Cystathionine Beta Synthase Display Increased Dyrk1A and SAHH Activities in Brain
Chris Planque et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
DYRK1A overexpression decreases plasma lecithin:cholesterol acyltransferase activity and apolipoprotein A-I levels
Asrna Tlili et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease
Hirosha Geekiyanage et al.
NEUROBIOLOGY OF AGING (2013)
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
Sylene Coutinho Rampche de Carvalho et al.
NUTRITION JOURNAL (2013)
FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons
Nobumasa Takasugi et al.
PLOS ONE (2013)
Homocysteine induces cerebral endothelial cell death by activating the acid sphingomyelinase ceramide pathway
Jiunn-Tay Lee et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Ceramide synthases at the centre of sphingolipid metabolism and biology
Thomas D. Mullen et al.
BIOCHEMICAL JOURNAL (2012)
Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide
M. J. Watt et al.
DIABETOLOGIA (2012)
Dynamics of DNA Methylation in Aging and Alzheimer's Disease
Hasan A. Irier et al.
DNA AND CELL BIOLOGY (2012)
Silencing of enzymes involved in ceramide biosynthesis causes distinct global alterations of lipid homeostasis and gene expression
Wanida Ruangsiriluk et al.
JOURNAL OF LIPID RESEARCH (2012)
Folate and vitamin B12 deficiency and hyperhomocysteinemia promote oxidative stress in adult type 2 diabetes
Masoud Y. Al-Maskari et al.
NUTRITION (2012)
Acid Sphingomyelinase Gene Knockout Ameliorates Hyperhomocysteinemic Glomerular Injury in Mice Lacking Cystathionine-β-Synthase
Krishna M. Boini et al.
PLOS ONE (2012)
Acid Sphingomyelinase Gene Deficiency Ameliorates the Hyperhomocysteinemia-Induced Glomerular Injury in Mice
Krishna M. Boini et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Homocysteine, Vitamin B12, and Folic Acid Levels in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: Baseline Characteristics in Subjects of the Australian Imaging Biomarker Lifestyle Study
Noel G. Faux et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Link Between DYRK1A Overexpression and Several-Fold Enhancement of Neurofibrillary Degeneration With 3-Repeat Tau Protein in Down Syndrome
Jerzy Wegiel et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
BACE1 Activity Is Modulated by Cell-Associated Sphingosine-1-Phosphate
Nobumasa Takasugi et al.
JOURNAL OF NEUROSCIENCE (2011)
High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway
Elena Bravo et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
Xianlin Han et al.
PLOS ONE (2011)
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
Christina Christoffersen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?
Jia-Min Zhuo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss
Michelle M. Mielke et al.
ALZHEIMERS & DEMENTIA (2010)
Diet-Induced Hyperhomocysteinemia Increases Amyloid-beta Formation and Deposition in a Mouse Model of Alzheimer's Disease
J. -M. Zhuo et al.
CURRENT ALZHEIMER RESEARCH (2010)
Normalization of hyperhomocysteinemia improves cognitive deficits and ameliorates brain amyloidosis of a transgenic mouse model of Alzheimer's disease
Jia-Min Zhuo et al.
FASEB JOURNAL (2010)
Homocysteine is associated with hippocampal and white matter atrophy in older subjects with mild hypertension
Michael J. Firbank et al.
INTERNATIONAL PSYCHOGERIATRICS (2010)
Ceramide-Mediated Insulin Resistance and Impairment of Cognitive-Motor Functions
Suzanne M. de la Monte et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Homocysteine, Another Risk Factor for Alzheimer Disease, Impairs Apolipoprotein E3 Function
Hirohisa Minagawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Sphingosine 1-Phosphate Lyase Deficiency Disrupts Lipid Homeostasis in Liver
Meryem Bektas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cognitive deficits and associated neurological complications in individuals with Down's syndrome
Ira T. Lott et al.
LANCET NEUROLOGY (2010)
Homocysteine and holotranscobalamin and the risk of Alzheimer disease A longitudinal study
B. Hooshmand et al.
NEUROLOGY (2010)
Hyperhomocysteinemia Increases beta-Amyloid by Enhancing Expression of gamma-Secretase and Phosphorylation of Amyloid Precursor Protein in Rat Brain
Chang-E Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Effect of hyperhomocysteinemia on the protein kinase DYRK1A in liver of mice
Julien Hamelet et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms
Ji Zhou et al.
BIOFACTORS (2009)
Homocysteine and lipids: S-Adenosyl methionine as a key intermediate
Rima Obeid et al.
FEBS LETTERS (2009)
Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic Steatohepatitis
Lascelles E. Lyn-Cook et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
The SPTLC3 Subunit of Serine Palmitoyltransferase Generates Short Chain Sphingoid Bases
Thorsten Hornemann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease ROLE OF STEAROYL-CoA DESATURASE
Zheng Zheng Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
DYRK1A, a Novel Determinant of the Methionine-Homocysteine Cycle in Different Mouse Models Overexpressing this Down-Syndrome-Associated Kinase
Christophe Noll et al.
PLOS ONE (2009)
Ceramide: A common pathway for atherosclerosis?
Jean Bismuth et al.
ATHEROSCLEROSIS (2008)
Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease
Soo-Ryoon Ryoo et al.
JOURNAL OF NEUROCHEMISTRY (2008)
B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-β deposition in mice
Andrea Fuso et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice
Wei-Na Cong et al.
LIFE SCIENCES (2008)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
DYRK1A-mediated hyperphosphorylation of Tau - A functional link between Down syndrome and Alzheimer disease
Soo-Ryoon Ryoo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: A shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
Pavel Katsel et al.
NEUROCHEMICAL RESEARCH (2007)
Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation
Estelle Sontag et al.
JOURNAL OF NEUROSCIENCE (2007)
Aβ peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine.: Physiological implications and relevance for Alzheimer's disease
L. F. Agnati et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A):: A gene with dosage effect during development and neurogenesis
M. Dierssen et al.
THESCIENTIFICWORLDJOURNAL (2006)
A model of insulin resistance and nonalcoholic steatohepatitis in rats -: Role of peroxisome proliferator-activated receptor-α and n-3 polyunsaturated fatty acid treatment on liver injury
Gianluca Svegliati-Baroni et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats
F. Yi et al.
KIDNEY INTERNATIONAL (2006)
Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels
Javier Pacheco-Quinto et al.
NEUROBIOLOGY OF DISEASE (2006)
Plasma homocysteine levels are not increased in murine models of Alzheimer's disease
D Santiard-Baron et al.
NEUROSCIENCE RESEARCH (2005)
Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease
M Gulsen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Vitamin B6 intake, alcohol consumption, and colorectal cancer:: A longitudinal population-based cohort of women
SC Larsson et al.
GASTROENTEROLOGY (2005)
Cystathionine β synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver
K Robert et al.
GASTROENTEROLOGY (2005)
The role of cystathionine β-synthase in homocysteine metabolism
KH Jhee et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?
E Steen et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
Recent concepts in non-alcoholic fatty liver disease
LA Adams et al.
DIABETIC MEDICINE (2005)
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease
RG Cutler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Abnormal lipid metabolism in cystathionine β-synthase-deficient mice, an animal model for hyperhomocysteinemia
K Namekata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Molecular machinery for non-vesicular trafficking of ceramide
K Hanada et al.
NATURE (2003)
Endoplasmic reticulum stress-inducible protein, herp, enhances presenilin-mediated generation of amyloid β-protein
X Sai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.
S Seshadri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways
GH Werstuck et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
